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Cholesterol is a critical component of cellular mem-
branes, regulating assembly and function of mem-
brane-based protein/lipid complexes. Many RNA
viruses, including enteroviruses, remodel host mem-
branes to generate organelles with unique lipid
blueprints on which they assemble replication com-
plexes and synthesize viral RNA. Here we find that
clathrin-mediated endocytosis (CME) is harnessed
by enteroviruses to traffic cholesterol from the
plasma membrane (PM) and extracellular medium
to replication organelles, where cholesterol then reg-
ulates viral polyprotein processing and facilitates
genome synthesis. When CME is disrupted, cellular
cholesterol pools are instead stored in lipid drop-
lets, cholesterol cannot be trafficked to replication
organelles, and replication is inhibited. In contrast,
replication is stimulated in cholesterol-elevated
cells like those lacking caveolins or those from Nie-
mann-Pick disease patients. Our findings indicate
cholesterol as a critical determinant for enteroviral
replication and outline roles for the endocytic
machinery in both the enteroviral life cycle and host
cell cholesterol homeostasis.
INTRODUCTION
Membranes often serve as platforms on which viral replication
machinery is assembled and genomes are replicated. Mem-
branes can potentially facilitate replication by limiting diffusion,
providing proper orientation of replication machinery, and
allowing greater sensitivity to changes in substrate/enzyme
concentrations (McCloskey and Poo 1986; den Boon and
Ahlquist 2010). These membranes utilized for replication, so-
called ‘‘replication organelles,’’ can originate from the endo-
plasmic reticulum (ER), the Golgi apparatus, the trans-GolgiCell Host & Mnetwork (TGN), endosomes, and even mitochondria (Miller
and Krijnse-Locker, 2008).
Enteroviruses are a family of nonenveloped (+) strand RNA
viruses that include many important human pathogens such as
poliovirus (PV), Coxsackievirus, human rhinovirus (HRV), entero-
virus, and echovirus. Upon infection, their (+) strand RNA
genome is translated into structural proteins and replication
machinery. The latter assembles on the cytosolic leaflet of host
membranes to synthesize RNA which is then either packaged
into virions or used as a template for further translation into struc-
tural and replication proteins (Paul et al., 1987). PV, Coxsackie-
virus B3 (CVB3), and Enterovirus 71 (EV71) all assemble their
replication complexes on phosphatidylinositol 4-phosphate
(PI4P) lipid enriched replication organelles by selectively recruit-
ing host type IIIb phosphatidylinositol 4-kinases (PI4KIIIb) to
membranes derived from ER exit sites (Hsu et al., 2010; Sasaki
et al., 2012; Greninger et al., 2012). Inhibiting PI4P production
blocks their replication, thus highlighting the critical role of lipids
in the enteroviral life cycle.
Discovery of PI4P lipids prompted us to seek additional lipid
signatures of replication organelles. Here we show that multi-
ple different enteroviruses exploit CME pathways and the
associated Rab11 recycling endocytic compartment to traffic
cholesterol from the PM and extracellular medium to replica-
tion organelle membranes. We demonstrate that cholesterol
facilitates viral RNA synthesis and regulates the proteolysis
of specific viral polyproteins required for initiating viral RNA
synthesis and packaging viral RNA. Finally we reveal a broader
role for CME machinery in shaping the cholesterol landscape
of mammalian cells where disruption of CME triggers storage
of PM cholesterol pools within lipid droplets. Although endo-
cytic machinery has been identified in previous host factor
screens, these studies have largely focused on endocytic
roles in viral attachment, entry, and export (Hsu and Spin-
dler, 2012; Mercer et al., 2010; Rowe et al., 2008). Our
studies reveal a role for endocytic machinery both in the viral
life cycle and in the maintenance of host cell cholesterol
homeostasis, and suggest new panviral therapeutic strate-
gies focused on blocking cholesterol trafficking to replication
organelle membranes.icrobe 14, 281–293, September 11, 2013 ª2013 Elsevier Inc. 281
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Figure 1. Disrupting Host Cell Endocytic Machinery Impacts Both Enteroviral Replication and Cellular Cholesterol Landscape
(A) CVB3 replication when CME components are depleted. Mean peak replication data ± SEM, from two independent experiments with six replicates each, were
normalized with respect to cell viability and plotted as percentage of nontarget siRNA-treated cells. **p < 0.01.
(legend continued on next page)
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Cell Host & Microbe
Enteroviral Replication Regulated by CholesterolRESULTS
Endocytic Machinery Regulates Enteroviral Replication
Downstream of Viral Entry
We first screened a subset of human genes with siRNA, targeting
those genes with established roles in CME including clathrin,
AP2, dynamin 2, Rab5, Rab11, Huntington interacting protein 1
(HIP1), Disabled 2 (DAB2), and Epsin15L for impact on entero-
viral replication. To separate impact on replication from viral
entry, disassembly, or export, siRNA-treated HeLa cells were
transfected with viral RNA replicons in which capsid-encoding
sequences had been replaced by Renilla luciferase, allowing
us to quantify viral RNA translation and synthesis by monitoring
bioluminescence.
We found that >75% depletion of CME components (see Fig-
ure S1A online) all resulted in significant inhibition of both CVB3
and PV replication (Figure 1A, Figure S1B, Table S1) and that
replication organelle biogenesis was disrupted (Figures S1C–
S1E). The replication measurements were normalized for cell
viability, which was largely unaffected by the siRNA treatments
(Table S1). In contrast, when we depleted caveolin-1 (Cav1) or
caveolin-2 (Cav2) proteins, which participate in non-clathrin-
mediated trafficking pathways, viral replication was stimulated
by up to 3-fold over nontarget siRNA-treated cells (Figure 1B,
Figure S1F, Table S1). Note that since Cav2 depletion did not
affect Cav1 levels, while Cav1 depletion decreased Cav2 levels,
this suggested that it is Cav2 that mediates the stimulation of
replication.
Notably there was no correlative impact of any of the endo-
cytic perturbations on the transfection/translation efficiency of
a reporter mRNA (Table S1), PKR antiviral response, or cellular
PI4P levels, which could account for the effects on replication
(Figures S1G and S1H). Furthermore, acute treatment of cells
with chlorpromazine, an inhibitor of CME, significantly blocked
viral replication (Figure S1I). Collectively, these findings indicate
a role for endocytic proteins in the viral lifecycle, downstream of
viral entry, regulating RNA replication.
Enhanced Esterification and Storage of Plasma
Membrane Cholesterol Pools when CME Is Disrupted
Cellular cholesterol homeostasis is established by vesicular and
nonvesicular cholesterol uptake and distribution, biosynthesis
and esterification of free cholesterol (i.e., membrane-bound) at
the ER, storage of free and esterified cholesterol within lipid
droplets, and cholesterol efflux (Ikonen, 2008). CME traffics sub-
cellular cholesterol pools, the LDL-receptor, which binds LDL-
cholesterol, and the NPC1L1 receptor, which binds cholesterol
micelles (Brown and Goldstein, 1986; Chang and Chang,
2008). Caveolins also have important roles in regulating the
cholesterol landscape of cells: helping organize PM cholesterol(B) PV and CVB3 replication when caveolins are depleted. Mean peak replication
normalized with respect to cell viability and plotted as percentage of nontarget s
(C) Plasma membrane cholesterol is stored in lipid droplets when CME compone
(D) Quantification of lipid droplets immunolabeled with anti-ADRP. Mean data ±
(E) Steady-state esterified cholesterol levels when CME components are deplete
(F) Steady-state free cholesterol (FC) and esterified cholesterol (EC) levels when c
each siRNA.
(G) Free cholesterol distribution when Cav 2 is depleted. Free cholesterol is labe
Figure 1 is related to Figure S1 and Table S1.
Cell Host & Mdomains, regulating cholesterol traffic to and from the PM, facil-
itating cholesterol efflux, and modulating cholesterol storage in
lipid droplets (Parton and del Pozo, 2013; Cohen et al., 2004;
Fu et al., 2004).
We first investigatedwhether therewas any common impact on
host cell cholesterol homeostasis when any of the CME compo-
nents were disrupted. In pulse-chase experiments with BODIPY-
cholesterol, a fluorescent live-cell mimic of free cholesterol,
which partitions into the PM bilayer when added exogenously
to the cells (Ho¨ltta¨-Vuori et al., 2008), we tracked the dynamics
of the PM free cholesterol pool, the largest reservoir for this lipid
in mammalian cells (Warnock et al., 1993). In nontarget, Cav1, or
Cav2 siRNA-treated cells, within 30 min of pulsing (for <3 min),
BODIPY-cholesterol had reached a steady-state distribution
among the PM, endocytic, and Golgi/TGN compartments (Fig-
ure 1C), similar to untagged-free cholesterol (Jansen et al., 2011).
In contrast, when cells had been depleted of CME compo-
nents, BODIPY-cholesterol was rapidly trafficked from the PM
to numerous, large spherical cytoplasmic puncta. These puncta
were determined to be lipid droplets by Nile Red stain (Figure 1C)
and antibodies against adipose differentiation-related protein
(ADRP) (Figure S1J). Lipid droplets, widely believed to originate
from ER membranes, are storage organelles for neutral lipids
including all esterified as well as some free cholesterol pools
(Hsieh et al., 2012; Prinz, 2013). At steady state these cells had
up to 6-fold more lipid droplets per cell than control cells
(Figure 1D, Figure S1J), and bulk measurements revealed an
3-fold increase in esterified cholesterol pools (Figure 1E), while
free cholesterol pools were minimally decreased (<20%) (Fig-
ure S1K). Consistent with activation of cholesterol storage path-
ways, we also measured a significant increase in cholesterol
esterification and storage activities at the ER (Figure S1L).
The ER increases its cholesterol esterification and storage
activities when its free cholesterol levels rise—for example, as
a result of cholesterol being trafficked to it (Brown andGoldstein,
1997, 1998). When we depleted clathrin from cells in LDL-
cholesterol-deficient media (i.e., media containing lipoprotein
deficient serum), cholesterol storage was still enhanced and
replication inhibited (Figures S1M and S1N). This indicated that
when CME was disrupted, the increased storage of cholesterol
was not a consequence of enhanced uptake and transfer of
LDL-derived cholesterol to the ER; rather, given the BODIPY-
cholesterol dynamics (Figure 1C), it suggested that intracellular
free cholesterol pools, primarily from the PM, were being traf-
ficked to the ER for storage in lipid droplets.
Increased Free Cholesterol Pools in Cav1- and Cav2-
Depleted Cells
On the other hand, in Cav1- or Cav2-depleted cells, esterified
cholesterol pool abundances were similar to control cells, butdata ± SEM from two independent experiments with six replicates each were
iRNA-treated cells. **p < 0.01.
nts are depleted. Scale bar, 5 mm.
SEM from n = 50 cells for each siRNA treatment are plotted.
d. Mean data ± SEM of three independent experiments for each siRNA.
aveolins are depleted. Mean data ± SEM of three independent experiments for
led with filipin. Scale bar, 5 mm.
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Figure 2. Enteroviral Replication Organelles Are Enriched in Cholesterol and PI4P Lipids
(A) Free cholesterol and PI4P distribution in mock infected HeLa cell. Scale bar, 5 mm.
(B–E) Free cholesterol and PI4P distribution in CVB3-, HRV2-, PV-, and Echovirus-infected cell replication organelles. Scale bar, 5 mm.
(F) SIM imaging of free cholesterol and PI4P distribution at CVB3 replication organelles.
Figure 2 is related to Figure S2.
Cell Host & Microbe
Enteroviral Replication Regulated by Cholesterolthere was up to 50% increase in free cholesterol pools (Fig-
ure 1F) which by filipin labeling, a fluorescent reporter that
selectively binds and sequesters free cholesterol within mem-
branes, was found to localize to the PM, the Golgi/TGN, and
recycling endosomes (Figure 1G, Figures S1O and S1P). This
increase in free cholesterol pools was not due to increased
cholesterol biosynthesis as determined by direct measure-
ments and nuclear SREBP2 levels (Figures S1L and S1Q).
However, when cells were depleted of caveolins in LDL-choles-
terol-deficient media, neither free cholesterol levels nor replica-
tion was increased (relative to control) (Figures S1R and S1S).
This indicated that the free cholesterol pools were being
derived from the LDL-cholesterol uptake pathway. Whether
clathrin-mediated LDL uptake is stimulated in the absence of
caveolins remains to be determined, but given that the ER in
caveolin-depleted cells does not sense an increase in choles-
terol levels—since cholesterol biosynthesis and esterification
are unaffected—this indicates that caveolins are modulating
LDL-cholesterol transfer to the ER, and/or the latter’s choles-
terol storage activities.284 Cell Host & Microbe 14, 281–293, September 11, 2013 ª2013 ElEnteroviral Replication Organelle Membranes Are
Enriched in Free Cholesterol
To determine whether the impact on viral replication of CME and
caveolin disruption could be through their modulation of the host
cholesterol landscape, we first investigated whether replication
organelle membranes themselves contained cholesterol. Using
filipin, in conjunction with antibodies against enteroviral replica-
tion proteins (3A, 3AB) and dsRNA,we obtained confocal images
of free cholesterol distribution within uninfected (Figure 2A) and
CVB3, PV (type 1 Mahoney), rhinovirus (type 2), or echovirus
(11 strain Gregory) infected cells at peak replication times (Fig-
ures 2B–2E). All replication organelles were enriched in free
cholesterol (Pearson coefficient of colocalization with replication
proteins: CVB3 0.70 ± 0.03 in n = 10 cells; PV 0.79 ± 0.04 in n = 10
cells), as well as PI4P lipids, the latter synthesized by PI4KIIIb,
whose inhibition blocked replication (Figures S2A and S2B;
Hsu et al., 2010).
Replication organelles are at the limit of resolution with con-
ventional diffraction limited microscopy (Belov et al., 2012), so
to obtain spatial information oncholesterol andPI4Porganizationsevier Inc.
Cell Host & Microbe
Enteroviral Replication Regulated by Cholesterolwithin replication organelles we utilized structured illumination
microscopy (SIM), which provides x and y axes resolution of
140 nm and z axis resolution of 250 nm (Gustafsson et al.,
2008). Live cells expressing FAPP1-mRFP to detect PI4P lipids
(Hsu et al., 2010) were pulsed with BODIPY-cholesterol and
allowed to reach steady-state distribution. Cells were then in-
fected with CVB3 for 4 hr. SIM imaging demonstrated that repli-
cation organelles have a nonuniform distribution of cholesterol,
with segregated cholesterol domains of 100–400 nm in size
(Figure 2F).
Cholesterol Facilitates Enteroviral RNA Synthesis
at Replication Organelles
We next investigated whether free cholesterol within replication
organelle membranes was required for replication. Previous
studies have focused on cholesterols’ role in regulating viral
attachment and viral entry, or mediating signaling for antiviral
immune responses (Howes et al., 2010; Mercer et al., 2010;
Mackenzie et al., 2007). We first determined that chronically
lowering intracellular free cholesterol pools (>50%) by growing
cells in serum-free media, LDL-deficient media, or LDL-deficient
media supplemented with Lovastatin, a blocker of cholesterol
biosynthesis (Krukemyer and Talbert, 1987) for up to 72 hr, all in-
hibited PV, CVB3, and rhinovirus replication (Figures S3A–S3C).
We next acutely depleted PM-free cholesterol pools by treat-
ing cells with methyl-b-cyclodextrin (MbCD) for 1 hr. Sub-
sequently cells were transfected with CVB3 or PV replicons
and replication data normalized by the transfection/translation
efficiency of a reporter RNA under similar conditions. Note that
MbCD treatment had no significant effect on PKR response (Fig-
ure S3D). After acutely lowering PM free cholesterol levels with
MbCD, we found a dose-dependent inhibition of replication
and replication organelle biogenesis (Figures 3A–3C). Signifi-
cantly, replication could be rescued by adding back cholesterol
(Figures 3B and Figure S3E), indicating that it had a facilitative
role for enteroviral replication.
To then determine the impact of cholesterol on viral RNA
translation and/or RNA synthesis, two processes which feed-
back on each other, we utilized a cell-free assay with isolated
membranes where translation and RNA synthesis could be un-
coupled (Barton and Flanegan, 1993). We disrupted the organi-
zation of free cholesterol and its abundance within membranes
by either filipin (Nichols et al., 2001) (Figure 3D) or MbCD treat-
ment, respectively (Figure S3F). Both methods of cholesterol
perturbation inhibited viral RNA synthesis but had no effect on
translation (Figure 3D). These findings suggest that free choles-
terol organization and abundance within replication organelle
membranes are critical for viral RNA synthesis.
Cholesterol Attenuates Enteroviral 3CDpro Polyprotein
Processing
The enteroviral genome is initially translated into a single poly-
protein, which is then proteolytically processed in sequential
steps into a repertoire of structural and replication proteins
(Paul et al., 1987). Given the small size of the viral genome
(8 kB), each proteolytic intermediate plays a distinct and impor-
tant role in replication. In particular, 3CDpro protein processing is
critical for replication. 3CDpro is a protease required for formation
of the replication complex, priming viral RNA synthesis, and pro-Cell Host & Mcessing capsids (Andino et al., 1990; Cornell and Semler 2002).
3CDpro is also cleaved autocatalytically in cis to produce 3Cpro
protease and 3Dpol proteins, where 3Cpro facilitates processing
of other viral proteins and 3Dpol is the RNA-dependent RNA po-
lymerase that replicates the genome.
We found that disrupting cholesterol organization or abun-
dance within membranes with filipin or MbCD, respectively,
stimulated the proteolytic processing of viral 3CDpro by almost
8-fold over mock treated cells (Figures 3E and 3F). This effect
was specific for 3CDpro, since neither 2BC (Figure S3G) nor
3AB protein processing (data not shown) was stimulated.
This steep decrease in 3CDpro levels, relative to other replication
proteins, would be prohibitive to both the initiation of viral RNA
synthesis and viral encapsidation. Thus our results suggest
that cholesterol is critical for regulating 3CDpro processing
kinetics and thereby the levels of 3CDpro, 3Cpro, and 3Dpol pro-
teins during infection.
Replication Is Stimulated in Free Cholesterol-Rich Cells
of Niemann-Pick Type C Disease
Consistent with cholesterol’s facilitative role in replication, repli-
cation organelles in caveolin-depleted cells, where replication
was stimulated, had 40% more cholesterol than did control
cells (Figures S4A and S4B). We next investigated the fate
of enteroviral replication in primary cells from individuals with
Niemann-Pick type C (NPC) disease where intracellular free
cholesterol levels are very high (Figure 4A) (Rosenbaum and
Maxfield, 2011). This disease has been assigned to the loss-of-
function mutations in NPC1 and/or NPC2 endosomal cholesterol
transporter proteins, which result in disruption of cholesterol
export out of endosomes while ER cholesterol biosynthesis is
continued.
Human primary wild-type (NPC1wt, NPC2wt) and mutant
(NPC1/, NPC2/) fibroblasts were transfected with PV
replicons, and replication was measured. We found an 3-fold
increase in replication in NPC1/and NPC2/ fibroblasts rela-
tive to wild-type along with an 3-fold increase in replication
organelle cholesterol (Figures 4B–4E). Note that replication
data were normalized by the transfection/translation efficiency
of a reporter RNA; and wild-type and mutant cell PKR responses
were similar (Figure S4C). Furthermore, lowering NPC cells’
cholesterol pools with MbCD inhibited replication by60% rela-
tive to mock-treated cells (Figure 4F), indicating that cholesterol
was responsible for stimulating replication in NPC cells. Finally,
3CDpro processingwas significantly attenuated in NPC cells (Fig-
ure 4G) as well as in caveolin-depleted cells relative to each
respective control cell (Figure S4D). This attenuation in 3CDpro
processing may account for the enhanced replication in NPC
cells or caveolin-depleted cells by promoting initiation of replica-
tion complexes and viral RNA encapsidation (Franco et al., 2005;
Molla et al., 1994).
Enteroviruses Stimulate the Net Uptake of Cholesterol
from the PM and Extracellular Medium by
Modulating CME
Given our findings, we conjectured that enteroviruses remodel
their hosts’ cholesterol landscape in order to enrich for free
cholesterol pools during infection. Supporting this conjecture,
our bulk cholesterol measurements revealed a net increase oficrobe 14, 281–293, September 11, 2013 ª2013 Elsevier Inc. 285
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Figure 3. Cholesterol Facilitates Viral RNA Synthesis and Attenuates Viral 3CDpro Processing
(A) Acute free cholesterol extraction from PM inhibits PV replication. Mean data ± SEM of PV replication and cholesterol levels are plotted (n = 50 cells for each
condition).
(B) Cholesterol rescuesCVB3 replicon replication.Mean data ± SEM from six replicates for each condition normalized by luciferasemRNA expression are plotted.
(C) Inhibition of replication organelle biogenesis after acute MbCD treatment. Antibodies against dsRNA and 3A proteins detect replication organelles. Scale
bar, 5 mm.
(D) Cell-free PV RNA translation and synthesis assay. Viral RNA synthesis assayed by 32P-CTP (top) and translation assayed by 35S-methionine labeling (bottom)
on filipin-treated membranes.
(E) Immunoblot analysis of 3CDpro, 2BC, and 3AB processing after mock, MbCD (1 hr pretreatment), or filipin treatment (at 3 hr pi). Viral proteins were harvested
at 5 hr pi.
(F) 3CDpro:3Dpol protein ratio after cholesterol perturbation. Mean data ± SEM from three independent experiments are plotted.
Figure 3 is related to Figure S3.
Cell Host & Microbe
Enteroviral Replication Regulated by Cholesterol40% in free cholesterol and a net decrease of 50% in esterified
cholesterol pools within PV- and CVB3-infected cells at peak
replication times relative tomock infectedcells (Figure5A, 4hrpi).
To determine the mechanisms underlying these changes, we
first measured the clathrin-mediated LDL-cholesterol uptake
during infection. We found it to be stimulated by 30% within
2 hr postinfection (pi) relative to control cells (Figure 5B, 2 hr
pi). But by 4 hr pi, LDL-cholesterol uptake was inhibited by
>50% (Figure 5B, 4 hr pi). Notably, when cells were transferred
into LDL-deficient media at 1 hr after replicon transfection, repli-
cation was significantly inhibited (Figure S3B), highlighting the
importance of LDL-cholesterol uptake early in replication. While
cholesterol biosynthesis was uninterrupted during infection, the286 Cell Host & Microbe 14, 281–293, September 11, 2013 ª2013 Elrate of synthesis paralleled the changes in LDL uptake,
decreasing by 30% within 2 hr pi (Figure 5C, 2 hr pi) but
increasing back to uninfected cell rates by peak replication
and later (Figure 5C, 4 hr pi and 6 hr pi). This increase likely re-
flects the impact of replication organelles emerging from the
ER, since they would be predicted to remove cholesterol. In
contrast to biosynthesis, cholesterol esterification was inhibited
throughout infection (Figure 5C, esterified), and lipid droplets
were depleted (Figure S5A). Note that host transcription and
translation are largely shut down by enteroviruses; thus these
changes in cholesterol homeostasis suggest posttranslational
viral modulation of host proteins regulating LDL uptake, esterifi-
cation, and biosynthesis. Indeed, HMG CoA reductasesevier Inc.
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Figure 4. High Free Cholesterol Pools in
Niemann-Pick Type C Disease Fibroblasts
Stimulate Replication
(A) Free cholesterol distribution in wild-type and
NPC2/ fibroblasts.
(B) PV replicon replication in wild-type and
NPC2/ fibroblasts. Mean data ± SEM with six
replicates each are plotted.
(C) Peak PV replication levels for wild-type,
NPC1/, and NPC2/ fibroblasts. Mean data ±
SEM from five independent experiments, normal-
ized by the expression of reporter luciferase RNA,
are plotted. ***p < 0.001.
(D) Cholesterol and viral dsRNA distribution in wild-
type and NPC2/ fibroblasts.
(E) Free cholesterol levels within WT and NPC2/
fibroblast replication organelles. Mean data ± SEM,
from wild-type (n = 30) and NPC2/ (n = 30)
fibroblasts, are plotted.
(F) Acute cholesterol extraction inhibits PV replicon
replication in NPC2/ fibroblasts. Mean data ±
SEM from two independent experiments are
plotted.
(G) 3CDpro/3Dpol ratio in wild-type and NPC2/
fibroblasts. Mean data ± SEM from three inde-
pendent experiments are plotted.
Scale bars, 10 mm.
Figure 4 is related to Figure S4.
Cell Host & Microbe
Enteroviral Replication Regulated by Cholesterolcholesterol biosynthesis enzyme levels and distribution were un-
changed during infection (Figures S5B and S5C).
We next investigated the dynamics of the PM free cholesterol
pools during infection. Cells expressing FAPP1-mRFP were
pulsed with BODIPY-cholesterol and incubated for 1 hr in order
for the label to reach steady-state distribution (Figure 5D, 0 hr).
Subsequently cells were CVB3 or mock infected, and confocal
time-lapse movies were taken for the duration of infection. In
contrast to mock infection (Figure 5D, 0 hr pi; Movie S1),
following CVB3 infection, there was rapid vesicular internaliza-
tion of PM cholesterol pools (Movie S2 and Movie S3). Within
2 hr pi >90% of the label had been depleted from the PM (Fig-
ure 5D, 2 hr pi; Figure 5E). Following internalizationmany of these
vesicles were observed fusing with and transferring their BOD-
IPY-cholesterol label to replication organelles emerging from
ER exit sites (Figure 5D, 4 hr pi; Movie S4).
BODIPY-cholesterol was frequently observed to colocalize
with clathrin-labeled vesicular structures within 2 hr pi (Figures
S5D and S5E). Acute treatment with dynasore, a noncompetitive
dynamin GTPase inhibitor (Macia et al., 2006) which disrupts
CME (Dutta and Donaldson 2012), blocked both BODIPY-
cholesterol and native cholesterol trafficking to replication
organelles (Figure 5F) and significantly decreased both replica-
tion (Figure 5G) and replication organelle cholesterol content
(Figures 5F and 5H). These data, together with stimulation ofCell Host & Microbe 14, 281–293, SLDL-cholesterol uptake (Figure 5B), indi-
cate that CME is virally modulated dur-
ing infection to enrich intracellular free
cholesterol pools and redistribute them
to replication organelles. One candidate
enteroviral protein to increase LDL andPM cholesterol uptake is 2BC. As previously reported (Cornell
et al., 2006), when ectopically expressed, 2BC increased the
endocytic uptake of AM4-65 lipid tracer from the PM by 4-
fold relative to mock, and significantly this uptake was sensitive
to dynasore treatment (Figures S5F and S5G). Furthermore,
2BC-expressing cells also had increased intracellular free
cholesterol pools (Figure S5H).
Enteroviral 3A Proteins Recruit Rab11 Recycling
Endosomes to Target Cholesterol to Replication
Organelles andPrevent It fromRecycling Back to thePM
We next investigated how internalized endosomal cholesterol
could be targeted to replication organelles, given that the latter
emerge from ER exit sites (Hsu et al., 2010). The temporal corre-
lation between the resumption of cholesterol biosynthesis and
replication organelle emergence from ER exit sites (Figure 5C)
suggests that some cholesterol is likely transferred from the
ER to replication organelles. In addition, within 2 hr of infection,
we found by confocal imaging and SIM that PM cholesterol pools
also redistributed to recycling endosomes containing Rab11
(Figures S6A and S6B).
By coexpressing Rab11-YFP and FAPP1mRFP, we investi-
gated the fate of recycling endosomes relative to replication
organelles during CVB3 infection. Time-lapse microscopy
revealed numerous Rab11-YFP recycling endosomes traffickingeptember 11, 2013 ª2013 Elsevier Inc. 287
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Figure 5. Enteroviruses Elevate Intracellular Free Cholesterol Pools
(A) Quantification of free and esterified cholesterol pools at 0 and 4 hr post CVB3 infection. Mean data ± SEM from three independent experiments are plotted.
(B) LDL uptake during CVB3 infection. Mean BODIPY-LDL uptake data from infected cells at 2 hr (n = 30) and 4 hr pi (n = 30) and for mock-infected cells at 4 hr pi
(n = 30) were plotted as percentage of uptake of mock-infected cells at 2 hr pi (n = 30) ± SEM.
(C) Free and esterified cholesterol biosynthesis at 0, 2, and 4 hr post CVB3 infection. Mean data ± SEM from one experiment with three replicates are plotted.
(D) Free cholesterol redistributes from PM to replication organelles during CVB3 infection. Cells expressing FAPP1-mRFP and colabeled with BODIPY-
cholesterol were infected and imaged by time-lapse confocal microscopy. See also Movie S1, Movie S2, Movie S3, and Movie S4. Scale bar, 5 mm.
(E) Quantification of plasma membrane BODIPY-cholesterol levels during CVB3 infection. Mean data ± SEM from mock (n = 10) and CVB3 (n = 10) infected cells
are plotted.
(F) Dynasore blocks BODIPY-cholesterol trafficking from plasma membrane to replication organelles. HeLa cells expressing FAPP1-mRFP were infected
with CVB3 for 3 hr, pulsed with BODIPY-cholesterol, and subsequently chased with either DMSO or Dynasore (80 mM) for 1 hr prior to confocal imaging. Scale
bar, 5 mm.
(G) Dynasore blocks CVB3 replication. DMSO- or Dynasore (80 mM)-treated cells were transfected with CVB3 replicons. Mean data ± SEM of peak replication
levels in three independent experiments for each condition are plotted.
(H) Dynasore blocks endogenous free cholesterol pools from trafficking to replication organelles. Experimental design similar to that in (F), but cells were fixed and
labeled with filipin and anti- 3A antibodies. Mean data ± SEM from n = 30 cells for each condition are plotted.
Figure 5 is related to Figure S5 and to Movie S1, Movie S2, Movie S3, and Movie S4.
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Enteroviral Replication Regulated by Cholesterolto andmergingwith FAPP1-mRFP-labeled replication organelles
(Figures 6B–6D; Movie S5 andMovie S6). Recruitment was recy-
cling endosome specific, since neither early nor late endosomal
markers localized to replication organelles (Figure S6C). Further-
more, as assessed by coimmunoprecipitation, the physical inter-
action between Rab11 and PI4KIIIb was significantly increased
by peak replication times even though respective protein abun-
dances were unchanged (Figure 6E).288 Cell Host & Microbe 14, 281–293, September 11, 2013 ª2013 ElWe found that ectopic expression of enteroviral 3A proteins
alone, which selectively enhance PI4KIIIb recruitment to mem-
branes (Greninger et al., 2012; Hsu et al., 2010), was also suffi-
cient to enhance Rab11 recruitment to the same membranes
(Figures 6F). While Rab11 recruitment was independent of
PI4P production by PI4KIIIb (Figure S6D), it remains to be deter-
minedwhether PI4KIIIb plays a scaffold role. Regardless, entero-
viral 3A proteins, by harnessing Rab11, can target cholesterol tosevier Inc.
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Figure 6. Enteroviral 3A Proteins Recruit
Rab11 Recycling Endosomes and Target
Free Cholesterol to Replication Organelles
(A) Live-cell SIM imaging of Rab11-YFP and
FAPP1-mRFP distribution in CVB3-infected cells at
peak replication. Insets highlight single-replication
organelles.
(B) Confocal time-lapse images of Rab11-YFP and
FAPP1-mRFP dynamics in CVB3-infected cells.
See also Movie S5. Scale bar, 5 mm.
(C) Fusion of Rab11-YFP recycling endosomes with
replication organelles in boxed region in (B). See
also Movie S6. Scale bar, 1 mm.
(D) Quantification of Rab11 colocalization with
FAPP1-labeled replication organelles. Mean Pear-
son correlation coefficients ± SEM are plotted (n = 5
cells for each time point).
(E) Enhanced coimmunoprecipitation of PI4KIIIb
with Rab11 in CVB3-infected cells at peak repli-
cation.
(F) Ectopic CVB3 3A expression recruits Rab11 to
3A-containing membranes. Scale bar, 5 mm.
(G) Ezetimibe inhibits PV replicon replication. Mean
peak replication data ± SEM of replicon transfected
cells from three independent experiments with six
replicates each are plotted. ***p < 0.001.
Figure 6 is related to Figure S6 and to Movie S5 and
Movie S6.
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This will result in increasing intracellular free cholesterol pools
(Figure 5A) and, together with PI4KIIIb, facilitate the biogenesis
of PI4P and cholesterol-enriched replication organelles.
Finally, acute treatment of cells with Ezetimibe, a highly spe-
cific inhibitor of the NPC1L1 cholesterol receptor (Chang and
Chang, 2008), blocked enteroviral replication (Figure 6G; Fig-
ure S6E). Since NPC1L1 traffics cholesterol via clathrin/AP2-
mediated endocytosis to Rab11 recycling endosomes (Wang
and Song 2012), these data provide further support for the viral
exploitation of the CME pathway for the enrichment and delivery
of cholesterol to replication organelles.
DISCUSSION
We have shown here that CME is harnessed by enteroviruses to
enrich intracellular free cholesterol pools (i.e., increase LDL
uptake, internalize PM cholesterol) and subsequently traffic
cholesterol to replication organelles where cholesterol modu-Cell Host & Microbe 14, 281–293, Slates proteolytic processing of viral 3CDpro
proteins and facilitates viral RNA synthe-
sis. Furthermore, we found that enteroviral
replication can be stimulated in cells with
high free cholesterol pools and functional
CME pathways, while replication is in-
hibited when CME is disrupted (Figure 7).
In the latter, CME machinery is not only
unavailable to traffic cholesterol to replica-
tion organelles, but PM free cholesterol
pools are instead trafficked to lipid drop-
lets for storage.Based on our findings, we propose the following model for the
role CME in regulating enteroviral replication. Early in infection,
there is a net increase in clathrin-mediated internalization of
cholesterol (i.e., LDL-cholesterol, NPC1L1-cholesterol, PM free
cholesterol). This is potentially modulated through the expres-
sion of newly synthesized viral 2BC proteins. A large fraction of
internalized cholesterol pools is then transported to recycling
endosomes, while the remainder traffics to the ER through
alternative pathways, leading to a decrease in cholesterol
biosynthesis. Furthermore, this decrease in biosynthesis may
be potentiated by the gradual absorption of cholesterol-rich
Golgi membranes into the ER, as a result of enteroviral 3A protein
interference with coatomer recruitment (Hsu et al., 2010; Wes-
sels et al., 2006).
By peak replication times (Figure 7A), replication organelles
have emerged from ER exit sites, carrying cholesterol away
from the ER and leading to the resumption of cholesterol biosyn-
thesis. Notably, cholesterol storage activities, through yet-un-
known mechanisms, are virally inhibited throughout infection,eptember 11, 2013 ª2013 Elsevier Inc. 289
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Figure 7. Cholesterol Landscape and Enteroviral Replication
(A) Upon infection, viral proteins (e.g., 2BC) modulate CME to enhance the net
uptake of PM and extracellular cholesterol pools. Internalized cholesterol is
pooled in Rab11 recycling endosomes and targeted to PI4P-enriched repli-
cation organelles via protein-protein interactions among viral 3A, Rab11, and
PI4KIIIb proteins. Additionally, some endocytosed cholesterol is transferred to
the replication organelles indirectly, through the ER, as the organelles emerge
from ER exit sites.
(B) Enteroviral replication is inhibited when CME is disrupted: cholesterol
cannot be internalized/transported to replication organelles; PM free choles-
terol pools are instead trafficked by alternate pathways to lipid droplets for
storage.
(C) Enteroviral replication is stimulated in cells with functional CME and high
free cholesterol pools at the PM and endosomal compartments (e.g., NPC,
Cav1, or Cav2 depleted).
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3A proteins, by recruitingRab11-positive recycling endosomes to
replication organelles along with PI4KIIIb, enrich these organelles
withboth free cholesterol andPI4P lipids, and thus facilitating viral
polyprotein processing and RNA synthesis. Targeting recycling
endosomes to replication organelles also prevents endocytosed
cholesterol pools, other lipids, and plasma membrane proteins,
such as LDL-receptor and MHC, from being recycled back to
the cell surface. Preventing LDL-receptor recycling may explain
the decrease observed in LDL uptake at peak replication, while
intracellular trapping of MHCmay contribute to evasion of the im-
mune system (Deitz et al., 2000; Cornell et al., 2006).
When free cholesterol is abundant, cells esterify and store
within lipid droplets some of their PM free cholesterol pools in or-
der to maintain cholesterol homeostasis (Lange et al., 1993).
Here we found that this process was enhanced when CME290 Cell Host & Microbe 14, 281–293, September 11, 2013 ª2013 Elwas disrupted (Figure 7B). While the mechanisms remain to be
determined, CME perturbation may trigger free cholesterol to
be trafficked to the ER by nonclathrin vesicular or entirely nonve-
sicular pathways such as direct exchange via ER-PM contact
sites or ORP carriers (English and Voeltz, 2013; Jansen et al.,
2011). Alternatively, the normal recycling of free cholesterol
pools back to the PM may be inhibited when CME is disrupted
(van Dam and Stoorvogel, 2002), thus resulting in transfer of
these pools to the ER for storage in lipid droplets. The physical
proximity of the ER to the PM and endosomes and the increase
in its esterification activity suggest that free cholesterol is traf-
ficked first to the ER prior to storage, although some fraction of
sterol may also be directly trafficked to the lipid droplets.
We found that disrupting CME machinery had an impact on
enteroviral replication opposite from the impact of disrupting
caveolins. The former not only resulted in PM free cholesterol
pools being routed for storage but also prevented enteroviruses
from harnessing the CME machinery to traffic these pools to
replication organelles. In contrast, in caveolin-depleted cells,
as well as in NPC cells, the presence of functional CME machin-
ery and abundant free cholesterol pools generated an ideal envi-
ronment within which enteroviruses could replicate (Figure 7C).
Notably, for NPC cells intracellular cholesterol trafficking from
the late endosomal stores to the PM occurs at a normal rate
(Lange et al., 2002). Thus, the reduction in movement of choles-
terol to the ER, a primary defect in NPC, may in fact promote
the availability of sterol from the PM for the viral replication
machinery.
For the majority of the siRNAs tested, their impact on CVB3
and PV replication was of similar magnitude, and small differ-
ences observed were potentially a consequence of differences
in replication kinetics, which may provide opportunity for cells
to mount antiviral responses, which, combined with CME loss,
can result in stronger inhibition of the slower replicating virus.
However, the impact of depleting DAB2, an adaptor for LDL-
receptor, was significantly greater on CVB3 than on PV, suggest-
ing a larger dependence of CVB3 on LDL to enhance cellular free
cholesterol pools.
Our data also revealed that by trafficking cholesterol to
PI4P-rich replication organelle membranes, enteroviruses might
be able to regulate the levels of 3CDpro proteins. Cholesterol
domains help partition and organize lipids and transmembrane
proteins within membrane bilayers (Simons and Sampaio,
2011; Lippincott-Schwartz and Phair, 2010; Bretscher and
Munro, 1993). Replication complex components 3CDpro, 3Cpro,
and 3Dpol all localize to PI4P-enriched membranes, and 3Dpol
has PI4P lipid-specific binding domains (Hsu et al., 2010).
PI4P-enriched membranes can be highly fluid (Zhendre et al.,
2011), which may prevent viral proteins from assembling on
them. Cholesterol can counter this fluidity and thereby may facil-
itate both replication complex assembly and position 3CDpro in a
specific conformation such that autocatalytic processing will be
attenuated.
Our findings here may also have implications for understand-
ing the pathogenesis of enteroviral infections. The cells of the
human gastrointestinal tract serve as initial replication sites
for many enteroviruses before dissemination to the rest of the
body (Bopegamage et al., 2005; Iwasaki et al., 2002). These
polarized cells are specialized for maximum absorption ofsevier Inc.
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PM (Jia et al., 2011). Thus they would be ideal for enteroviral
replication: high cholesterol absorption along with functional
CME machinery, including Rab11 recycling endosomes through
which both apical and basolateral PM cholesterol pools can
be trafficked (Maxfield and Wu¨stner, 2002). Furthermore, mice
made hypercholesterolemic by diet develop infections with
high enteroviral loads, but whether this is due to compromised
antiviral responses or enhanced replication remains to be inves-
tigated (Campbell et al., 1982).
Finally, cholesterol is a highly abundant critical component of
the central and peripheral nervous systems (Chang et al., 2010;
Karasinska and Hayden, 2011). In Alzheimer’s disease (AD) and
Huntington disease (HD), disruptions of both CME and choles-
terol homeostasis have been frequently reported, including a
significant increase in the number of neuronal lipid droplets con-
taining esterified cholesterol (Area-Gomez et al., 2012; Li and
DiFiglia, 2012; Martinez-Vicente et al., 2010; Chang et al.,
2010; Cataldo et al., 2000). Huntingtin protein, the primary caus-
ative agent for HD, interacts with HIP1 and clathrin (Velier et al.,
1998), and mutant huntingtin expression alone can disrupt CME
and cholesterol homeostasis (Trushina et al., 2006). Similarly, in
AD, amyloid b proteins were shown to cause CME defects
(Treusch et al., 2011), and enhanced cholesterol esterification,
the latter a hallmark of familial AD (Area-Gomez et al., 2012;
Chang et al., 2010). Indeed, blocking cholesterol esterification al-
leviates AD symptoms and reduces amyloid plaque formation
(Bryleva et al., 2010). Our findings here coupling the disruption
of CME with accumulation of esterified cholesterol may provide
insight and therapeutic strategies for these neurological condi-
tions. At any rate, whenever CME components are perturbed,
the latter’s impact on cholesterol homeostasis should be given
consideration when interpreting experimental results.
In summary, our results identify a wider role of host endocytic
proteins in shaping the cellular cholesterol landscape and im-
pacting the viral life cycle beyond attachment, entry, and export.
These findings may provide new panviral therapeutic strategies
for treating enteroviral infections including blocking cholesterol
uptake or biosynthesis, stimulating cholesterol storage, and pre-
venting cholesterol from being trafficked to replication organ-
elles by disrupting the viral recruitment of Rab11 proteins.
EXPERIMENTAL PROCEDURES
Confocal Time-Lapse Imaging and Immunofluorescence
Confocal time-lapse imaging and immunofluorescence were performed as
described (Hsu et al., 2010). All images were analyzed with Zeiss LSM or
ImageJ software.
Super-Resolution 3D-SIM Imaging
Super-resolution 3D-SIM imaging was performed on a Zeiss ELYRA S.1
system (Carl Zeiss, USA). Images were acquired with a Plan-Apochromat
633/1.40 oil immersion objective and an Andor iXon 885 EMCCD camera.
Fifteen images per plane (five phases, three rotations) and 0.125 mm z section
of 3 mm height were required for generating superresolution images. Raw
images were reconstructed and processed to demonstrate structure with
greater resolution by the ZEN 2011 microscope software (Carl Zeiss, USA).
Cell Viability Quantification
Optimal plasmid expression times, siRNA, and drug concentrations/incuba-
tion times that maximize cell viability were assessed both by quantificationCell Host & Mof cell number and by CellTiter-Glo cell viability assays (Promega Corp, WI).
Plasmid concentration range and siRNA concentration range tested were
0.1 mg/ml–1 mg/ml and 25 nM–100 nM, respectively.
Lipid Assays
Lipid Loading
Top Fluor (BODIPY) cholesterol in complex with MbCD at a molar ratio 1:10
was applied to cells. BODIPY-LDL was loaded at 20 mg/ml in FBS free medium
for 20 min at 37C.
Lipid Staining
Nile Red and Filipin III were utilized at 0.5 mg/ml for 5 min and 50 mg/ml, for 30
min, respectively.
Transfections
All DNA transfections were performed with Fugene 6 reagent (Roche Applied
Science, IN). All siRNA transfections were performed with Dharmafect 1
(Dharmacon, CO).
Replicon Assays
Replicon assays were performed as described in Hsu et al. (2010). Capped
Firefly luciferase mRNA containing poly(A) tail was used for control of RNA
transfection.
Chemical Treatments and Analysis
Cells were incubated in Lovastatin (Enzo Life Sciences Inc., NY) (5–25 mM) or
lovastatin with mevalonate (Sigma, MO) (250 mM) for 72 hr in media with 5%
lipoprotein-depleted serum (Milipore, MA). Cholesterol was depleted by incu-
bating HeLa or NPC cells with 10mMMbCD for 1 or 2 hr, respectively, at 37C.
Dynasore (Sigma) was used at 80 mM; Ezetimibe (Santa Cruz Inc, CA) con-
centration rangewas 1–30 mM; PIK93 (Knight et al., 2006) (Symansis, Auckland
New Zealand) concentration range was 500 nM–1 mM.
Cell-free Translation and Replication Assays
Cell-free translation and replication assays were performed as described in
Hsu et al. (2010).
Cholesterol Quantification
Free and esterified cholesterol was determined enzymatically using Amplex
Red (Invitrogen). Samples were diluted to equal amount of protein.
Statistical Analysis
Data were expressed and plotted as means ± SEM. Unpaired Student’s t tests
were used to compare the mean of control and experimental groups. The
actual p value and sample size of each experimental group are provided in
the respective figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six movies, six figures, one table,
Supplemental Experimental Procedures, and Supplemental References
and can be found with this article online at http://dx.doi.org/10.1016/j.chom.
2013.08.002.
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